10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in...
News
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020
Data presented throughout 2020 have validated the potential of the PATrOL™ platform to develop highly targeted therapies that increase, decrease...
Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
BATON ROUGE, La., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and...
Acasti Pharma Unaware of Any Material Change
LAVAL, Québec, Dec. 23, 2020 (GLOBE NEWSWIRE) -- At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”)...
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
GAITHERSBURG, Md., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the...
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
Ziopharm to Participate in Upcoming January Conferences
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced that Laurence...
Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
Mechelen, Belgium; 23 December 2020, 18.00 CET – Galapagos NV (Euronext & NASDAQ: GLPG) today announces that Onno van de...
Franklin Woods Center Among the First Long-Term Care Facilities in Maryland to Vaccinate Residents and Healthcare Workers
KENNETT SQUARE, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Franklin Woods Center, a Genesis HealthCare- (NYSE:GEN) (Genesis or the Company)...
LifeLabs Confirms that all Members of Santa’s Workshop Have Tested Negative for COVID-19
Santa and team have been cleared for international travel ahead of Christmas LifeLabs Confirms that all Members of Santa’s Workshop...
Elmcroft by Eclipse Senior Living Begins Vaccinating Residents and Associates
Raymond Gano, a resident at Eclipse Senior Living's Elmcroft of Martinsburg community, receives his vaccination. Raymond Gano, a resident at...
Allogene Therapeutics Receives IND Clearance from the U.S. Food and Drug Administration for ALLO-715 in Combination with Nirogacestat in Relapsed/Refractory Multiple Myeloma
Combination Represents One of Allogene’s Three Strategies to Target BCMA for Multiple MyelomaPhase 1 Clinical Trial Expected to Begin in...
Palvella Therapeutics Reports Top-Line Results from Pivotal Phase 2/3 VALO Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel in Patients with Pachyonychia Congenita
~ VALO Study Misses Primary Endpoint in Phase 3 Randomized Withdrawal Portion ~ ~ VALO Study Achieves Primary Endpoint in...
Vincera Pharma Announces Completion of Business Combination and Listing on Nasdaq
Business combination transaction with LifeSci Acquisition Corp. was completed on December 23, 2020 Combined company renamed Vincera Pharma, Inc., common...
UPDATE – GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering
Will Trade on the Nasdaq Global Market Under Ticker “GBS”NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the...
Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations
- Patent relates to a solution of eflornithine for oral administration currently being evaluated in Orbus’ Phase 3 STELLAR study...
Financing to support Spineway development strategy
Press release Ecully, 22 December 2020, 10 p.m. Financing planNew tranche of Negma convertible bonds In keeping with its development...
Information about mandatory offer of share repurchase
Information about mandatory offer of share repurchase Joint Stock Company “Grindeks” hereby informs that today according to 22nd December, 2020 Financial...
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
Shares of Yumanity to commence trading on Nasdaq under new ticker symbol “YMTX” on December 23, 2020 $33.6 million common...
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
All planned clinical trials for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) wet AMD BLA now fully enrolled or completedPivotal data expected in...